Canadian Implant Recall Contrasts Food and Drug Administration’s Stance
On Jun. 7, 2019, Health Canada provided two published articles detailing breast implant models that were being voluntarily recalled by Allergan. The Canadian implant recall took place because “Health Canada has suspended the licenses for Allergan's BioCell textured breast implants . . . , based upon the rare but serious risk of … [Read more...] about Canadian Implant Recall Contrasts Food and Drug Administration’s Stance
Silicone Breast Implants Come Under Scrutiny By The FDA
Breast implants are a common procedure around the world. Tens of millions of women receive them for reconstructive or cosmetic reasons in the U.S. alone. With such a common procedure affecting so many women, any rare side effects could affect tens of thousands of people. Parker Waichman has already extensively covered the risk of … [Read more...] about Silicone Breast Implants Come Under Scrutiny By The FDA
FDA Update on Breast Implant Safety
Breast Implant Safety. Five years after re-approving silicone gel breast implants for augmentation, the U.S. Food & Drug Administration (FDA) is updating the public on the safety issues posed by the devices. The FDA's update is based on preliminary results of studies that Allergan and Mentor were ordered to conduct in the wake of … [Read more...] about FDA Update on Breast Implant Safety
Rare Lymphoma in Breast Implant Patients
Breast Implant Patients Linked To Lymphoma. Breast implants, long touted as safe medical devices, are now being linked with a rare type of lymphoma. According to an alert from the Food & Drug Administration (FDA), its recent review of the medical literature identified 34 unique cases of anaplastic large cell lymphoma (ALCL) in … [Read more...] about Rare Lymphoma in Breast Implant Patients
